UCB SA (Germany) Top Insiders

UNC Stock  EUR 245.90  2.00  0.81%   
UCB SA employs about 8.6 K people. The company is managed by 20 executives with a total tenure of roughly 20067 years, averaging almost 1003.0 years of service per executive, having 430.0 employees per reported executive. Examination of UCB SA's management performance can provide insight into the company performance.
Gwendoline Ornigg  Executive
Head Communication
Thomas Debeys  Executive
Head Audit
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UCB SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

UCB SA Management Team Effectiveness

The company has return on total asset (ROA) of 0.07 % which means that it generated a profit of $0.07 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1491 %, meaning that it generated $0.1491 on every $100 dollars invested by stockholders. UCB SA's management efficiency ratios could be used to measure how well UCB SA manages its routine affairs as well as how well it operates its assets and liabilities. The current Total Assets is estimated to decrease to about 13.6 B. The UCB SA's current Net Tangible Assets is estimated to increase to about (1.2 B)

UCB SA Quarterly Income Before Tax

208.5 Million

The UCB SA's current Net Income Applicable To Common Shares is estimated to increase to about 667.1 M, while Common Stock Shares Outstanding is projected to decrease to roughly 208.1 M. UCB SA secures a total of 190 Million outstanding shares. UCB SA shows substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as UCB SA in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of UCB SA, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

UCB SA Workforce Comparison

UCB SA is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2.24 Million. UCB SA adds roughly 8,600 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.3 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.3.

UCB SA Benchmark Summation

The output start index for this execution was one with a total number of output elements of sixty. The Lowest value over a specified period line plots minimum value of UCB SA price series.

UCB SA Notable Stakeholders

An UCB SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as UCB SA often face trade-offs trying to please all of them. UCB SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting UCB SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sandrine CFAExecutive CFOProfile
Martin CitronVP MedicinesProfile
Gwendoline OrniggHead CommunicationProfile
Thomas DebeysHead AuditProfile
Fiona MonceauExecutive OfficerProfile
Veronique ToullyCorporate SustainabilityProfile
Raf RemijsenHead ManagementProfile
William SilbeyExec CounselProfile
Charl ZylEx EUInternationalProfile
Denelle JDExecutive CounselProfile
Roger PalframanHead USProfile
Mary McHaleHead ManagementProfile
Caroline VancoillieChief FunctionsProfile
Alistair HenryExecutive OfficerProfile
JeanChristophe TellierCEO DirectorProfile
Emmanuel CaeymaexExecutive EvidenceProfile
Pr LowFriedrichChief VPProfile
Kirsten LundJurgensenExecutive SupplyProfile
JeanLuc FleurialExecutive OfficerProfile
Antje WitteHead RelationsProfile
String symbol = request.getParameter("s");

About UCB SA Management Performance

The success or failure of an entity such as UCB SA often depends on how effective the management is. UCB SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of UCB management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the UCB management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
UCB SA, a biopharmaceutical company, develops therapies and solutions for people with neurology and immunology diseases. The company was founded in 1928 and is headquartered in Brussels, Belgium. UCB S operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 7600 people.

UCB SA Workforce Analysis

Traditionally, organizations such as UCB SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare UCB SA within its industry.

UCB SA Manpower Efficiency

Return on UCB SA Manpower

Revenue Per Employee715.3K
Revenue Per Executive307.6M
Net Income Per Employee123.8K
Net Income Per Executive53.2M
Working Capital Per Employee146.4K
Working Capital Per Executive63M

Complementary Tools for UCB Stock analysis

When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance